Radiolabelled Molecules for Brain Imaging with PET and SPECT
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging methods which are widely used in nuclear medicine for diagnosis and treatment follow-up of many major diseases. These methods use target-specific molecules as probes, which are lab...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (244 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545740404498 |
---|---|
ctrlnum |
(CKB)5400000000041088 (oapen)https://directory.doabooks.org/handle/20.500.12854/69348 (EXLCZ)995400000000041088 |
collection |
bib_alma |
record_format |
marc |
spelling |
Brust, Peter edt Radiolabelled Molecules for Brain Imaging with PET and SPECT Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (244 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging methods which are widely used in nuclear medicine for diagnosis and treatment follow-up of many major diseases. These methods use target-specific molecules as probes, which are labeled with radionuclides of short half-lives that are synthesized prior to the imaging studies. These probes are called radiopharmaceuticals. The use of PET and SPECT for brain imaging is of special significance since the brain controls all the body’s functions by processing information from the whole body and the outside world. It is the source of thoughts, intelligence, memory, speech, creativity, emotion, sensory functions, motion control, and other important body functions. Protected by the skull and the blood–brain barrier, the brain is somehow a privileged organ with regard to nutrient supply, immune response, and accessibility for diagnostic and therapeutic measures. Invasive procedures are rather limited for the latter purposes. Therefore, noninvasive imaging with PET and SPECT has gained high importance for a great variety of brain diseases, including neurodegenerative diseases, motor dysfunctions, stroke, epilepsy, psychiatric diseases, and brain tumors. This Special Issue focuses on radiolabeled molecules that are used for these purposes, with special emphasis on neurodegenerative diseases and brain tumors. English Research & information: general bicssc Biology, life sciences bicssc SV2A SV2B SV2C microPET [18F]UCB-H epilepsy PBIF distribution volume blocking assay preclinical imaging Alzheimer’s disease (AD) network measure graph theory brain network positron emission tomography (PET) persistent homology Phosphodiesterase 2A (PDE2A) Positron Emission Tomography (PET) Benzoimidazotriazine (BIT) fluorinated Mouse Liver Microsomes (MLM) cyclic nucleotide phosphodiesterase PDE2A radioligand nitro-precursor fluorine-18 in vitro autoradiography PET imaging opioid receptors positron emission tomography radiotracers μOR-, δOR-, κOR- and ORL1-ligands movement disorders pain drug dependence GBM biomarkers Sigma 1 Sigma 2 PD-L1 PARP IDH Alzheimer’s disease Parkinson’s disease β-amyloid plaques neurofibrillary tangles α-synucleinopathy diagnostic imaging probes orexin receptors PET radiotracer imaging alpha 7 nicotinic acetylcholine receptors nAChR autoradiography amino acid FET FACBC FDOPA immunoPET molecular imaging glioma brain metastases adenosine A2A receptor rotenone-based mouse model [18F]FESCH two-step one-pot radiosynthesis 3-03936-720-X 3-03936-721-8 Brust, Peter oth |
language |
English |
format |
eBook |
author2 |
Brust, Peter |
author_facet |
Brust, Peter |
author2_variant |
p b pb |
author2_role |
Sonstige |
title |
Radiolabelled Molecules for Brain Imaging with PET and SPECT |
spellingShingle |
Radiolabelled Molecules for Brain Imaging with PET and SPECT |
title_full |
Radiolabelled Molecules for Brain Imaging with PET and SPECT |
title_fullStr |
Radiolabelled Molecules for Brain Imaging with PET and SPECT |
title_full_unstemmed |
Radiolabelled Molecules for Brain Imaging with PET and SPECT |
title_auth |
Radiolabelled Molecules for Brain Imaging with PET and SPECT |
title_new |
Radiolabelled Molecules for Brain Imaging with PET and SPECT |
title_sort |
radiolabelled molecules for brain imaging with pet and spect |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (244 p.) |
isbn |
3-03936-720-X 3-03936-721-8 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT brustpeter radiolabelledmoleculesforbrainimagingwithpetandspect |
status_str |
n |
ids_txt_mv |
(CKB)5400000000041088 (oapen)https://directory.doabooks.org/handle/20.500.12854/69348 (EXLCZ)995400000000041088 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Radiolabelled Molecules for Brain Imaging with PET and SPECT |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548726550593536 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04608nam-a2201105z--4500</leader><controlfield tag="001">993545740404498</controlfield><controlfield tag="005">20231214133416.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000041088</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69348</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000041088</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brust, Peter</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Radiolabelled Molecules for Brain Imaging with PET and SPECT</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (244 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging methods which are widely used in nuclear medicine for diagnosis and treatment follow-up of many major diseases. These methods use target-specific molecules as probes, which are labeled with radionuclides of short half-lives that are synthesized prior to the imaging studies. These probes are called radiopharmaceuticals. The use of PET and SPECT for brain imaging is of special significance since the brain controls all the body’s functions by processing information from the whole body and the outside world. It is the source of thoughts, intelligence, memory, speech, creativity, emotion, sensory functions, motion control, and other important body functions. Protected by the skull and the blood–brain barrier, the brain is somehow a privileged organ with regard to nutrient supply, immune response, and accessibility for diagnostic and therapeutic measures. Invasive procedures are rather limited for the latter purposes. Therefore, noninvasive imaging with PET and SPECT has gained high importance for a great variety of brain diseases, including neurodegenerative diseases, motor dysfunctions, stroke, epilepsy, psychiatric diseases, and brain tumors. This Special Issue focuses on radiolabeled molecules that are used for these purposes, with special emphasis on neurodegenerative diseases and brain tumors.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Research & information: general</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biology, life sciences</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SV2A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SV2B</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SV2C</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microPET</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">[18F]UCB-H</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epilepsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PBIF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">distribution volume</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">blocking assay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">preclinical imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Alzheimer’s disease (AD)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">network measure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">graph theory</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain network</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">positron emission tomography (PET)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">persistent homology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Phosphodiesterase 2A (PDE2A)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Positron Emission Tomography (PET)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Benzoimidazotriazine (BIT)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluorinated</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mouse Liver Microsomes (MLM)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cyclic nucleotide phosphodiesterase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PDE2A radioligand</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nitro-precursor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluorine-18</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro autoradiography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PET imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">opioid receptors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">positron emission tomography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotracers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">μOR-, δOR-, κOR- and ORL1-ligands</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">movement disorders</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug dependence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GBM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sigma 1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sigma 2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-L1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PARP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IDH</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Alzheimer’s disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Parkinson’s disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">β-amyloid plaques</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurofibrillary tangles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">α-synucleinopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diagnostic imaging probes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">orexin receptors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PET</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotracer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">alpha 7</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nicotinic acetylcholine receptors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nAChR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autoradiography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">amino acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FET</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FACBC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FDOPA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunoPET</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain metastases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adenosine A2A receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rotenone-based mouse model</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">[18F]FESCH</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">two-step one-pot radiosynthesis</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-720-X</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-721-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brust, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:53:15 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338054690004498&Force_direct=true</subfield><subfield code="Z">5338054690004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338054690004498</subfield></datafield></record></collection> |